Heart Failure NYHA Class II Clinical Trial
Official title:
Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients
The two primary goals of it's management are preventing further disease progression(mortality,hospitalizations and deterioration of left ventricular function)and alleviating patient suffering
Heart failure (HF) is emerging as an epidemic in 3rd world countries. Despite significant therapeutic advances, patients with chronic heart failure remain at high risk for HF progression and death. The two primary goals of its management are preventing further disease progression(mortality, hospitalizations and deterioration of left ventricular function)and alleviating patient suffering.Sacubitril /valsartan (previously known as LCZ696) is a first-in-class medicine that contains a neprilysin (NEP )inhibitor(sacubitril) and an angiotensin II receptor blocker (valsartan). NEP is an endopeptidase that metabolizes different vasoactive peptides including natriuretic peptides, bradykinin and Ang -II. In consequence, its inhibition increases mainly the levels of both natriuretic peptides (promoting diuresis, natriuresis and vasodilation) and Ang- II whose effects are blocked by the angiotensin receptor blocker, valsartan (reducing vasoconstriction and aldosterone release). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04452149 -
Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure
|
N/A | |
| Withdrawn |
NCT03005184 -
Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2
|
Phase 2 | |
| Not yet recruiting |
NCT01669395 -
Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial
|
N/A | |
| Recruiting |
NCT05835063 -
A Study to Improve Physician-Youth Communication and Medical Decision Making
|
N/A | |
| Completed |
NCT03895073 -
HEart fAiluRe evaluaTion Questionnaire
|
||
| Completed |
NCT03095196 -
Multipolar CRT-d and Diabetes
|
N/A | |
| Recruiting |
NCT03180320 -
Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)
|
N/A | |
| Completed |
NCT06233695 -
Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure
|
||
| Completed |
NCT04741191 -
Cycle Ergometer Training and Heart Failure on Heart Rate Recovery and Mind Fullness
|
N/A | |
| Withdrawn |
NCT03947853 -
Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure
|
||
| Recruiting |
NCT05934487 -
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
|
N/A | |
| Recruiting |
NCT04829617 -
Promoting Well-being and Health in Heart Failure
|
N/A | |
| Recruiting |
NCT05487365 -
Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF
|
N/A | |
| Completed |
NCT01560871 -
Effects of a Walking Program and Inspiratory Muscle Training in Individuals With Chronic Heart Failure
|
N/A | |
| Completed |
NCT03387813 -
Hemodynamic-GUIDEd Management of Heart Failure
|
N/A | |
| Enrolling by invitation |
NCT05885607 -
Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure
|
||
| Completed |
NCT06394986 -
Cardio-fistular Recirculation in Patients With Chronic Heart Failure and Preserved Left Ventricle Ejection Fraction
|
||
| Terminated |
NCT04971993 -
Step and Walking Pattern From Cardiac Monitor Study
|
||
| Completed |
NCT04180696 -
Mid-Q Response Study
|
N/A | |
| Not yet recruiting |
NCT05702970 -
Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency
|
Phase 4 |